In a press release dated May 25, 2021, PatientBond announced that it was recognized by KLAS and G2 for high customer satisfaction. Moreover, PatientBond was listed among the Financial Times list of the Americas Fastest Growing Companies 2021.
KLAS provides accurate, honest and impartial insights for the healthcare IT (HIT) industry through strong relationships and balanced interviews with payers and providers. KLAS is widely accepted in the healthcare community as a highly credible and reliable source of intelligence on HIT vendors, products and services.
KLAS evaluated PatientBond for the first time in April 2021 for the Patient Engagement category, in which PatientBond achieved 95% Overall Customer Satisfaction, placing it solidly among the top vendors in the category. Specifically, PatientBond received an A grade for customer peer recommendations and executive involvement. Mike Davis, HCIT market research and analysis expert, writes in KLAS' Points to Ponder in the PatientBond Spotlight Report:
"PatientBond provides a patient engagement and communication environment based on psychographic algorithms that enables more effective patient engagement touches. Patient categorization/segmentation capabilities based on emotional models allow more effective market programs and patient access services, along with higher collection levels for patient-owed payments. PatientBond is recognized by its clients as being highly responsive to service requests and application updates. Effectively engaging and targeting patient populations by their emotional profiles is a unique approach for patient engagement that is proving to be successful."
KLAS interviewed current PatientBond customers and the following are a sample of the quotes from the KLAS' PatientBond Spotlight Report:
“I would definitely recommend PatientBond's solution. If anyone is looking for a solution to allow providers to connect emotionally with existing and potential patients, PatientBond's system is the easiest off-the-shelf solution in the healthcare industry. The system is customizable, and that is really important. We wanted to be able to segment patients and communicate with them directly in an emotional language that they would understand; that was a very important outcome that we hoped to achieve." - Vice President
"There are vendors and there are partners, and I have always considered PatientBond a solid, very good partner. They are people we can talk to and we can get to their executives. They will try to work through a solution with us, and that is high praise because a lot of vendors cannot do that or don't have a platform that is flexible enough that they can provide those customized solutions. I have always been impressed with PatientBond in that way. We talk to their executives all the time." - CIO
"The vendor was very upfront about what we would pay for the solution. Exactly what the vendor said was exactly what we got. PatientBond's solution saves us an inordinate amount of time and money. There is really no other vendor doing the type of graphic profiling that PatientBond is doing right now." - Vice President
In response to this report, Justin Dearborn, CEO of PatientBond, stated, "We are excited to be rated so highly with KLAS. This is consistent with Patientbond's 82 Net Promoter Score (NPS), which has held steady over the years and significantly exceeds the IT industry average of 33, underscoring our commitment to customer success."
PatientBond also achieved High Performer status on the influential G2 website for healthcare organizations to evaluate technology vendors prior to making purchase decisions. According to its website, G2 is the world’s largest tech marketplace where businesses can discover, review, and manage the technology they need to reach their potential.
A Communications Manager leaving a review on the G2 site stated, "Not only is their product extremely beneficial and valuable to our business, but the people who work there make it even better. Their customer service is top-notch and they make you feel like you're always a priority and well taken care of."
When listing PatientBond's advantages in a review on the G2 site, a VP of Population Health wrote, "The strong scientific underpinnings of their approach; the flexibility and willingness to customize; the transparency; the actionability and applicability of those insights."
This customer feedback is a strong indicator of PatientBond's success and ability to bring innovation to the marketplace. PatientBond's dedication to its customers has resulted in strong and steady business growth.
PatientBond gained additional recognition in April when it was named in the top 20% of the Financial Times The America's Fastest Growing Companies 2021. This honor is given to independent companies who have hit revenue growth targets organically over a three-year period out of tens of thousands of companies in the Americas. This is the second year in a row that PatientBond has achieved this honor.
Mr. Dearborn continued, "PatientBond has been growing rapidly by helping our customers improve patient interactions, resulting in improved cash flow through increased patient volume and financial responsibility payments while reducing costs through automation. We are fortunate to have a strong team and product to support our valued customers."
PatientBond is the only digital patient engagement platform that leverages consumer science and psychographics to motivate and activate patient behaviors. PatientBond’s mission is to leverage Healthcare Consumer Insights and Innovative Technology Solutions to help its clients build a tighter bond with their patients to improve health outcomes, increase revenue and reduce costs. PatientBond is currently used by more than 1,200 healthcare provider locations across the United States. PatientBond is a portfolio company of First Health Capital Partners, LLC. Information about PatientBond is available at www.patientbond.com.